MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$49,726K
Free Cash flow
$16,815K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of investme...
Gain on sale of prv
Fair value adjustment related to...
Others
Negative Cash Flow Breakdown
Gain on sale of future royalties...
Purchases of investments
Accounts and other receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
8,752
37,890
12,165
-544
Stock-based compensation expense
2,969
3,105
4,284
2,771
Impairment of intangible assets
0
-
0
58,710
Inventory obsolescence charge
0
485
0
0
Income tax expense
703
6,914
501
-433
Depreciation and amortization expense
364
368
362
392
Non-cash interest expense
-
-
612
685
Non-cash lease expense
122
118
602
-
Non-cash interest expense
1
341
-
-
Fair value adjustment related to warrant and cvr liability
6,408
-968
-3,557
5,506
Accretion on investments
595
624
857
1,211
Fair value adjustment related to investments
140
216
-30
-124
Loss on extinguishment of debt
0
-2,756
-
-
Loss on derivative liability
0
-7,216
-
-
Cash paid to settle derivative instrument and payoff premium
0
9,016
-
-
Settlement of royalties to aquestive
-500
-4,393
-
-
Paid-in-kind interest
0
3,134
-
-
Loss on sublease and disposal of property and equipment
-
-
63
-
Gain on sale of future royalties, intellectual property, and other assets, net
43,314
-
-
-
Consulting fees paid in common stock
0
0
0
0
(gain) loss on foreign currency exchange rates
406
1,403
-1,422
5
Gain on sale of prv
-43,314
43,314
0
148,325
Accounts and other receivables
5,740
-6,890
6,367
-1,359
Prepaid expenses and other current assets
-149
-2,053
-399
3,046
Inventories
140
185
525
194
Other long-term assets
-45
-
-451
-
Operating lease right-of-use assets
234
476
-
-1,274
Other long-term assets
-
87
-
-
Accounts payable and accrued expenses
2,320
-529
412
-4,730
Discount and rebate liabilities
2,307
1,150
2,166
1,469
Operating lease liabilities
-111
-123
-129
-1,292
Other liabilities
391
416
-5,982
2,832
Net cash provided by (used in) operating activities
17,032
6,142
5,516
4,709
Sale of future royalties, intellectual property, and other assets, net
5,000
43,935
-
-
Purchases of property and equipment
217
35
-31
554
Disposals of property and equipment
-
42
-141
589
Purchases of investments
22,540
58,296
87,163
65,111
Sales and maturities of investments
49,250
93,972
87,500
60,500
Proceeds from sale of prv
0
-
0
0
Payment of royalty to xoma
-
-
0
-
Net cash provided by investing activities
31,451
79,618
227
-4,576
Proceeds from issuance of debt, net of lender fees
-
-
-
0
Payment of third-party debt issuance costs
-
-
-
0
Proceeds from issuance of debt, net of lender fees
-
-
0
-
Repayment of debt
0
60,092
0
0
Proceeds from insurance financing arrangements
-
-
0
0
Payments for employee taxes related to stock awards
-1,150
2,635
-
-
Proceeds from employee stock purchase plan
434
-
202
0
Proceeds from issuance of stock
-
-
0
0
Proceeds from issuance of common stock for options exercised
1
752
-338
3,520
Proceeds from issuance of common stock for warrants exercised
0
9,171
2,682
5,957
Payments of principal on insurance financing arrangements
0
0
0
0
Payment of deferred financing costs
-
-
0
-
Net cash (used in) provided by financing activities
1,585
-52,804
2,546
6,530
Effect of exchange rate changes on cash and cash equivalents
-342
233
-322
64
Net increase in cash and cash equivalents
49,726
33,189
7,967
6,727
Cash and cash equivalents, beginning of period
95,595
62,406
54,439
33,785
Cash and cash equivalents, end of period
145,321
95,595
62,406
54,439
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Sales and maturities
of investments
$49,250K
(61.48%↑ Y/Y)
Gain on sale of prv
-$43,314K
(-129.20%↓ Y/Y)
Payments for employee
taxes related to stock...
-$1,150K
Proceeds from employee
stock purchase plan
$434K
(5.08%↑ Y/Y)
Proceeds from issuance of
common stock for...
$1K
(-99.97%↓ Y/Y)
Sale of future
royalties, intellectual...
$5,000K
Net income
$8,752K
(-87.78%↓ Y/Y)
Fair value
adjustment related to...
$6,408K
(255.27%↑ Y/Y)
Stock-based compensation
expense
$2,969K
(-46.78%↓ Y/Y)
Accounts payable and
accrued expenses
$2,320K
(120.59%↑ Y/Y)
Discount and rebate
liabilities
$2,307K
(-24.31%↓ Y/Y)
Income tax expense
$703K
(-79.21%↓ Y/Y)
Other liabilities
$391K
(-80.36%↓ Y/Y)
Depreciation and
amortization expense
$364K
(-88.97%↓ Y/Y)
Prepaid expenses and
other current assets
-$149K
(-150.34%↓ Y/Y)
Fair value
adjustment related to...
$140K
(2700.00%↑ Y/Y)
Non-cash lease expense
$122K
Other long-term
assets
-$45K
Non-cash interest
expense
$1K
(-99.93%↓ Y/Y)
Net cash provided by
investing activities
$31,451K
(39.93%↑ Y/Y)
Net cash provided by
(used in) operating...
$17,032K
(244.06%↑ Y/Y)
Net cash (used in)
provided by financing...
$1,585K
(-46.95%↓ Y/Y)
Canceled cashflow
$22,757K
Canceled cashflow
$51,040K
Net increase in cash
and cash...
$49,726K
(257.05%↑ Y/Y)
Canceled cashflow
$342K
Purchases of investments
$22,540K
(-85.71%↓ Y/Y)
Purchases of property and
equipment
$217K
(-30.45%↓ Y/Y)
Gain on sale of future
royalties, intellectual...
$43,314K
Accounts and other
receivables
$5,740K
(-17.64%↓ Y/Y)
Accretion on investments
$595K
(-43.87%↓ Y/Y)
Settlement of royalties to
aquestive
-$500K
(gain) loss on foreign
currency exchange rates
$406K
(409.92%↑ Y/Y)
Operating lease
right-of-use assets
$234K
(-70.68%↓ Y/Y)
Inventories
$140K
(-76.11%↓ Y/Y)
Operating lease
liabilities
-$111K
(-114.88%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$342K
(-219.58%↓ Y/Y)
Buy us a coffee
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)